Flow cytometry in the diagnosis of cancer

References

• Flow Cytometry and Sorting, M R Melamed, T Lindmo, M I Mendelsohn. Wiley-Liss, Inc., New York 1990
   Google Scholar
• Orfao A., Ruiz Argelles A. Citometria de flujo y su aplicacùln en hematologÂa. Enciclopedia de HematologÂa Iberoamericana, A Lilpez Borrasca, C L Arocha Pirango, C Campos Guerra, A Parreira, S Pavlosky, G Ruiz-Arguelles, J F San Miguel. Ediciones Universidad de Salamanca, Salamanca 1993; 161–175
   Google Scholar
• Fuhr J E, Frye A, Kattine A A, Van Meter S. Flow cytometrc determination of breast tumour heterogeneity. Cancer 1991; 67: 1401–5
   PubMed Web of Science ®Google Scholar
• Merkel M R, Dressler L G, McGuire W L. Flow cytometric cellular DNA content and prognosis in human malignancy. J Clin Oncol 1987; 5: 1690–703
   PubMed Web of Science ®Google Scholar
• Keren D F, Hanson C A, Hurtubise P E. Flow cytometry and clinical diagnosis. ASCP Press, Chicago 1994
   Google Scholar
• Yen A. Flow cytometry Advanced Research and Clinical Applications. CRC Press INC., Boca Raton, Florida 1989
   Google Scholar
• Robinson R A. Defining the limits of DNA cytometry. Am J Clin Pathol 1992; 92: 275–7
   Google Scholar
• Lovett E L, Schnitzer B, Keren D F. Application of flow cytometry to diagnostic pathology. Lab Invest 1984; 50115–40
   Google Scholar
• Rijken A, Dekker A, Taylor S. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. Am J Clin Pathol 1991; 95: 6–12
   PubMed Web of Science ®Google Scholar
• Barlogie B, Raber M N, Schumann J, Johnson T S, Drewiko B, Swartzendruber D E, Gohde W, Andreef M, Freireich E. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 3982–97
   PubMed Web of Science ®Google Scholar
• Quirke P, Dyson JED. Flow cytometry: methodology and applications in pathology. J Pathol 1986; 149: 79–87
   PubMed Web of Science ®Google Scholar
• Baker R M, Fredericks W J, Chen Y F. Detection of P-glycoprotein in human turnours. Cancer Invest 1990; 8: 255–6
   PubMedGoogle Scholar
• Flow cytogenetics, J Gray. Academic Press, London 1989
   Google Scholar
• Orfao A, Ciudad J, Lopez-Berges M C, Lopez A, Vidriales B, Caballero M D, Valverde B, Gonzalez M, San Miguel J F. Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry. Leuk Lymph 1994; 13: 87–90, supl. 1
   PubMed Web of Science ®Google Scholar
• Campana D, Coustan-Smith E, Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood 1990; 76: 163–71
   PubMed Web of Science ®Google Scholar
• Orfao A, Gonqlez M, Ciudad J, Lilpez-Berges M C, Lgpez A, Vidriales B, Macedo A, San Miguel J F. Cell cycle and DNA aneuploidy: Biological bases and terminology I. DNA cytometric analysis, A Sampedro, A Orfao. Universidad de Oviedo, Oviedo 1993; 13–24
   Google Scholar
• Hedley D W, Shankey T V, Wheeless L L. DNA Cytometry Consensus Conference. Cytometry 1993; 14: 471
   PubMedGoogle Scholar
• Cusick E L, Milton J I, Ewen SWB. The resolution of aneuploid DNA stemline by cytometry: limitations by coefficient of variation and the percentage of aneuploid nuclei. Anal Cell Pathol 1990; 2: 139–48
   PubMedGoogle Scholar
• Duque R E, Andreeff M, Braylan R C, Diamond L W, Peiper S C. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 1993; 14: 492–6
   PubMedGoogle Scholar
• Joensuu H, Klemi P J. DNA aneuploidy in adenomas of endocrine organs. Am J Pathol 1988; 132: 145–51
   PubMedGoogle Scholar
• Teyssier J R, Liautaud-Roger F, Ferre D, Patey M, Dufer J. Chromosomal changes in thyroid tumours. Relation with DNA content, Karyotypic features, and clinical data. Cancer Genet Cytogenetic 1990; 50: 249–63
   PubMedGoogle Scholar
• Löfberg R, Tribukait B, Ost A. Flow cytometric DNA analysis in long-standing ulcerative colitis. A method of prediction of dysplasia and carcinoma development? Gut 1987; 28: 1100–6
   Google Scholar
• Friedlander M L, Russell P, Taylor I W. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian turnours of borderline malignancy. Pathology 1984; 16: 301–6
   PubMed Web of Science ®Google Scholar
• Bauer K D, Bagwell C B, Giaretti W, Melamed M, Zarbo R J, Witzig T E, Rabinovitch P T. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993; 14: 486–91
   PubMedGoogle Scholar
• Hedley D W, Clark G M, Cornelisse C J, Killander D, Kute T, Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 1993; 14: 482–5
   PubMedGoogle Scholar
• Shankey T V, Kallionierni O, Koslowski J M, Lieber M L, Mayall B H, Miller G, Srmth G H. Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 1993; 14: 497–500
   PubMedGoogle Scholar
• Wheeless L L, Badalament R A, de Vere White R W, Fradet Y, Tribukait B. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 1993; 14: 478–81
   PubMedGoogle Scholar
• Garcia Garcia J, de la Muiioz Espada, Merlo-Cordoba J B, Orfao de Matos A, Ciudad Pizarro J, Gomez Alonso A. Correlaciun clÂnico-biolùgica y caracterÂsticas del ADN en 74 pacientes con cancer colorrectal (citometrÂa de flujo de piezas en fresco). Cir Esp 1992; 51: 16–20
   Google Scholar
• Paz-Bouza J I, Orfao A, Abad M M, Ciudad J, Garcia M C, Lopez A, Bullon A. Transrectal fine-needle aspiration biopsy of the prostate combining cytomorphologic, DNA ploidy status and cell cycle distribution studies. Pathol Res Practice 1994; 190: 682–9
   PubMedGoogle Scholar
• Garcia-Sanz R, Orfao A, Gonzalez M, Moro M J, Hernandez J M, Ortega F, Borrego D, Camero M, Casanova F, Jimenez R, Portera J A, San Miguel J F. Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. Br J Haematol 1995, in press
   PubMedGoogle Scholar
• Look A T, Roberons P K., Williams D L. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985; 65: 1079–86
   PubMed Web of Science ®Google Scholar
• Shankey T V, Rabinovitch P S, Bagwell B, Bauer K D, Duque R E, Hedley D W, Mayall B H, Wheeless L. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14: 482–5
   PubMedGoogle Scholar
• Darzynkiewicz Z. Mammalian cell-cycle analysis. The cell cycle, P Fantes, R Brooks. Oxford University Press, New York 1993; 45–68
   Google Scholar
• Flow cytometry; instrumentation and data analysis, M A Van Dilla, P N Dean, O D Laerum, M R Melamed. Academic Press, London 1985
   Google Scholar
• Orfao A, Garcia-Sanz R, Lopez-Berges M C, Vidriales M B, Gonzalez M, Caballero M D, San Miguel J F. A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining techniqhe. Cytometry 1994; 17: 332–9
   PubMedGoogle Scholar
• San Miguel J F, Garcia-Sanz R, Gonzalez M, Moro M J, Hernandez J M, Ortega F, Borrego D, Camero M., Casanova F, Jimenez R, Portera J A, Orfao A. A new staging system for multiple myeloma based on the number of S-phase plasma cells. Blood 1995; 85: 448–55
   PubMed Web of Science ®Google Scholar
• Bennet J M, Catovsky D, Daniel M T, Flandrin G, Galton DAG, Gralnick H R, Sultan C. Proposals for the classification of acute leukemias. A report of the French-American-British Cooperative Group. British Journal of Haematology 1976; 33: 451–8
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel D, Flandrin M T, Galton DAG, Gralnick H R, Sultan C. (The French-American-British FAB Cooperative Group): Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 1989; 42: 567–84
   PubMed Web of Science ®Google Scholar
• Gomez E, San Miguel J F, Gonzalez M, Orfao A, Caûizo M C, Moraleda J M, Lopez Borrasca A. The value of the immunological subtypes and individual markers compared to classical parameters in the prognosis of acute lymphoblastic leukaemia. Hematol Oncol 1991; 9: 33–42
   PubMed Web of Science ®Google Scholar
• Hernandez J M, Gonzalez-Sarmiento R, Martin C, Gonzalez M, Sanchez I, Corral J, Orfao A, Cauizo M C, San Miguel J F, Lopez Borrasca A. Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia. Br J Haematol 1991; 79: 414–9
   Google Scholar
• Hernandez J M, San Miguel J F, Gonzalez M, Orfao A, Caûizo M C, Bascones C, Hernandez J, Lopez Borrasca A. Development of acute leukaemia after idiopathic myelofibrosis. J Clin Pathol 1992; 45: 427–30
   PubMed Web of Science ®Google Scholar
• Hernandez J M, Orfao A, Gonzalez M, Cuesta B, Lopez-Berges M C, Cauizo M C, Ciudad J, San Miguel J F. Immunophenotypic characterisation of acute leukaemia after polycythemia Vera. J Clin Pathol 1993; 46: 668–71
   PubMed Web of Science ®Google Scholar
• San Miguel J F, Hernandez J M, Gonqlez-Sarmiento R, Gonzalez M, Sanchez I, Orfao A, Caûizo M C, Lopez Borrasca A. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic and clinical characteristics. Blood 1991; 78: 768–74
   PubMed Web of Science ®Google Scholar
• San Miguel J F, Gonzalez M, Caûizo M C, Ojeda E, Orfao A, Caballero M D, Moro M J, Fisac P, Lopez Borrasca A. Leukemias with megakaryoblastic involvement: clinical, hematologic and immunologic characteristics. Blood 1988; 72: 402–7
   PubMed Web of Science ®Google Scholar
• San Miguel J F, Fisac P, Gonzalez M, Calmuntia M J, Hernandez J, Bascones C. Immunological phenotype of the microgranular variant of acute promyelocytic leukemia. Haematologia 1986; 20: 49–50
   Google Scholar
• Mecucci C, van den Berghe H. Cytogenetics and immunophenotype. Leuk Lymph 1994; 13: 49–51, suppl. 1
   PubMed Web of Science ®Google Scholar
• San Miguel J F, Gonzalez M, Canizo M C, Anta J P, Zola H, Lopez Borrasca A. Surface marker analysis in acute myeloid leukemia and correlation with FAB classification. Br J Haematol 1986; 64: 547–603
   PubMed Web of Science ®Google Scholar
• Second MIC Cooperative Study Group: Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukemias. Br J Haematol 1988; 68: 487–94
   PubMed Web of Science ®Google Scholar
• Matutes E, Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk Lymph 1994; 13: 11–4, suppl. 1
   PubMed Web of Science ®Google Scholar
• Weinberg O S, Pinkus G S, Auk K. A Cytofluorimetric detection of B cell clonal excess: a new approach to the diagnosis of B cell lymphoma. Blood 1984; 63: 1080–5
   PubMed Web of Science ®Google Scholar
• McKenna R W. lyphoproliferative disorders of granular lymphocytes. More questions than answers. Arch Pathol Lab Med 1992; 116: 235–7
   PubMedGoogle Scholar
• Vidriales M B, Orfao A, Lopez-Berges M C, Gonzalez M, Lopez-Macedo A, Ciudad J, Lopez A, Garcia M A, Hernandez J, Borrego D, San Miguel J F. Prognostic value of S-phase cells in AML patients. Br J Haematol 1995; 89, in press
   Google Scholar
• Orfao A, Vidriales M B, Gonzalez M, Lopez-Berges M C, Canizo M C, San Miguel J F. Diagnostic and prognostic importance of immunophenotyping in adults with acute myeloid leukemia. Recent Results in Cancer Research. Recent advances in tumour cell biology of acute leukemias: impact on clinical diagnosis and therapy, W D Ludwig, E Thiel. Springer-Verlag, Berlin 1993; 369–379
   Google Scholar
• Drexler H G, Thiel E, Ludwig D. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991; 5: 637–45
   PubMed Web of Science ®Google Scholar
• Begg A C, McNally N J, Shrieve D C, Karcher H. A method to measure the duration of DNA- synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–6
   PubMedGoogle Scholar
• Danova M, Riccardi A, Mazzini G. Cell cycle-related proteins and flow cytometry. Haematologica 1990; 129: 329–33
   Google Scholar
• Mateo M S, Sanchez-Beato M, Martinez J C, Orfao A, Orradre J L, Piris M A. p53, RB and bcl2 expression along the cell cycle. A study on PHA-stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J Clin Pathol 1995, in press
   PubMedGoogle Scholar
• Hedley D W, Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 1994; 15: 349–58
   PubMedGoogle Scholar
• Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz M A, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795–808
   PubMedGoogle Scholar
• Redner A, Melamed M R, Andreeff M. Detection of central nervous system relapse in acute leukemia by multiparameter flow cytometry of DNA, RNA, and CALLA. NY Acad Sci 1986; 468: 241–255
   PubMedGoogle Scholar
• Stonesifer K J, Xiang J, Wilkinson E T. Flow cytometric analysis and cytopathology of body cavity fluids. Acta Cytol 1987; 31: 125–30
   PubMedGoogle Scholar
• Deinlein E, Sanders U, Greiner C. Diagnostic significance of flow cytometric DNA analysis applied for the detection of the cancer cells in bronchial washing fluid. Anal Quant Cytol Histol 1988; 10: 360–4
   PubMedGoogle Scholar
• Macedo A, Orfao A, Martinez A, Vidriales M B, Valverde B, Lopez-Berges M C, San Miguel J F. Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML. Br J Haematol 1995, in press
   PubMedGoogle Scholar
• Macedo A, Orfao A, Vidriales M B, Lopez-Berges M C, Valverde B, Gonzalez M, Caballero M D, Ramos F, Martinez M, San Miguel J F. Aberrant phenotypes for the detection of minimal residual disease in acute myeloid leukemia. Ann Hematol 1995, in press
   PubMedGoogle Scholar
• Arkesteijn GJA, Erpelinck S L, Martens A C, Hagenbeek A. In suspension hybridization of cells with chromosome specific DNA probes, analysis by dual-laser beam flow cytometry and its application for residual leukemia cells. Cytometry 1994; 40, suppl. 7
   Google Scholar